WebJan 6, 2024 · Under the partnership, LakePharma will manufacture Akston’s adjuvanted Covid-19 vaccine candidate, AKS-452. ... LakePharma president and CEO Hua Tu said: “We bring three critical components to this partnership: our experience in making SARS-CoV-2 proteins, our stable CHO-GSN technology, and most importantly, the use of the … WebFeb 12, 2024 · "The new facility is ideal for LakePharma as it provides the ability to offer fully integrated contract development and manufacturing organization (CDMO) capabilities," said Hua Tu, LakePharma's CEO.
Curia Completes Acquisition of LakePharma - Curia Global
WebApr 20, 2024 · Hua Tu, co-founder and CEO of Lake Pharma Inc., with company … WebMay 2, 2024 · This work made LakePharma realize the second step: The diagnostic community could benefit from using these proteins to develop diagnostic tests. Most COVID-19 testing currently is a nasal swab ... sunova koers
Curia Acquires LakePharma; Thermo Fisher, Cytiva Expand …
WebMar 22, 2016 · /PRNewswire/ -- LakePharma, Inc., ... broad expertise and quality … WebMay 24, 2024 · Panelists included biotech C-level executive Hua Tu, LH Capital Director Matt Crommett, and Health Wildcatters CEO and co-founder Hubert Zajicek. ... His former company—Bay Area-based LakePharma—was outgrowing its locations in Belmont, California, and the Boston region. It needed a bigger footprint to accommodate its … WebSep 6, 2024 · LakePharma will operate as part of Curia’s R&D division, led by Christopher Conway, President, R&D. Hua Tu, LakePharma’s founder and CEO, will serve on Curia’s executive team as CTO. LakePharma and its ‘The Biologics Company’ brand will migrate to the Curia brand in the future. It will continue to use its name for an interim period ... sunova nz